A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This study was not conducted in the United States. The purpose of this study was to assess
the safety and effectiveness of a number of doses of vildagliptin, an unapproved drug, in the
treatment of people with type 2 diabetes.